Vietnam Cryptococcal Retention in Care Study Version 1.0
Status:
Unknown status
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
It is hypothesized that implementing plasma CrAg screening in clinics providing routine HIV
care will enable identification of Vietnamese adult patients with advanced HIV (CD4 ≤100
cells/μL) who have early cryptococcal disease, enable prompt preemptive treatment with
high-dose fluconazole, and improve survival.
Details
Lead Sponsor:
National Hospital for Tropical Diseases, Hanoi, Vietnam